Synthesis of (±)-Emtricitabine and (±)-Lamivudine by Chlorotrimethylsilane-Sodium Iodide-Promoted Vorbrüggen Glycosylation

J Org Chem. 2022 Mar 4;87(5):2887-2897. doi: 10.1021/acs.joc.1c02772. Epub 2022 Jan 14.

Abstract

By simple combination of water and sodium iodide (NaI) with chlorotrimethylsilane (TMSCl), promotion of a Vorbrüggen glycosylation en route to essential HIV drugs emtricitabine (FTC) and lamivudine (3TC) is achieved. TMSCl-NaI in wet solvent (0.1 M water) activates a 1,3-oxathiolanyl acetate donor for N-glycosylation of silylated cytosine derivatives, leading to cis-oxathiolane products with up to 95% yield and >20:1 dr. This telescoped sequence is followed by recrystallization and borohydride reduction, resulting in rapid synthesis of (±)-FTC/3TC from a tartrate diester.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-HIV Agents* / pharmacology
  • Deoxycytidine / therapeutic use
  • Emtricitabine / therapeutic use
  • Glycosylation
  • HIV Infections* / drug therapy
  • HIV-1*
  • Humans
  • Lamivudine / therapeutic use
  • Sodium Iodide / therapeutic use
  • Trimethylsilyl Compounds
  • Water

Substances

  • Anti-HIV Agents
  • Trimethylsilyl Compounds
  • Water
  • Deoxycytidine
  • Lamivudine
  • trimethylchlorosilane
  • Sodium Iodide
  • Emtricitabine